<DOC>
	<DOCNO>NCT00262548</DOCNO>
	<brief_summary>The purpose study determine whether treatment rosuvastatin 6 month obese type 2 diabetic woman improve lipid profile thus prevent progression cardiovascular disease .</brief_summary>
	<brief_title>C-Reactive Protein ( CRP ) Obese Diabetic Women</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Menopausal Diagnosed diabetes mellitus type 2 Obese ( body mass index [ BMI ] &gt; 25 ≤ 30 ) Fasting blood glucose ≥ 200 mg/dl CRP &lt; 2 mg/L &gt; 10 mg/L</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Menopause</keyword>
</DOC>